サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1319946

治療用BCGワクチン市場：タイプ別（免疫BCG、治療BCG）、人口動態別（成人、小児科）、エンドユーザー別-2023-2030年の世界予測

Therapeutic BCG Vaccine Market by Type (Immune BCG, Therapy BCG), Demographics (Adults, Pediatrics), End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
治療用BCGワクチン市場：タイプ別（免疫BCG、治療BCG）、人口動態別（成人、小児科）、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

治療用BCGワクチンの世界市場は大きく成長すると予測され、2023年には5,776万米ドル、CAGRは4.48%と予測され、2030年には驚異的な7,863万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の治療用BCGワクチン市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.治療用BCGワクチンの世界市場規模および予測は？

2.予測期間中、世界の治療用BCGワクチン市場を形成するCOVID-19の阻害要因と影響は？

3.治療用BCGワクチンの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.治療用BCGワクチンの世界市場における競争戦略は？

5.治療用BCGワクチンの世界市場における技術動向と規制の枠組みは？

6.治療用BCGワクチンの世界市場における主要ベンダーの市場シェアは？

7.治療用BCGワクチンの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 乳児人口の増加と小児医療の進歩
      • 治療用BCGワクチンの研究開発に多額の投資を行った
      • ワクチン接種キャンペーンを通じて意識を高める
    • 抑制要因
      • 治療用BCGワクチンが不足しています
    • 機会
      • 発展途上国および後進国における未開拓の市場
      • 国連（UN）による結核予防への取り組みの拡大
    • 課題
      • BCGワクチンに伴う副作用
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 治療用BCGワクチン市場：タイプ別

  • 免疫BCG
  • BCG療法

第7章 治療用BCGワクチン市場人口統計別

  • 大人
  • 小児科

第8章 治療用BCGワクチン市場：エンドユーザー別

  • クリニック
  • 病院

第9章 南北アメリカの治療用BCGワクチン市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の治療用BCGワクチン市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの治療用BCGワクチン市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. THERAPEUTIC BCG VACCINE MARKET RESEARCH PROCESS
  • FIGURE 2. THERAPEUTIC BCG VACCINE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. THERAPEUTIC BCG VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2022 VS 2030 (%)
  • FIGURE 6. THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 7. THERAPEUTIC BCG VACCINE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. THERAPEUTIC BCG VACCINE MARKET DYNAMICS
  • FIGURE 9. THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. THERAPEUTIC BCG VACCINE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. THERAPEUTIC BCG VACCINE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. THERAPEUTIC BCG VACCINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. THERAPEUTIC BCG VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. THERAPEUTIC BCG VACCINE MARKET SIZE, BY IMMUNE BCG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. THERAPEUTIC BCG VACCINE MARKET SIZE, BY THERAPY BCG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 8. THERAPEUTIC BCG VACCINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. THERAPEUTIC BCG VACCINE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 11. THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. THERAPEUTIC BCG VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. SINGAPORE THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. SINGAPORE THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. TAIWAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. TAIWAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. VIETNAM THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. VIETNAM THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. THERAPEUTIC BCG VACCINE MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 141. THERAPEUTIC BCG VACCINE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 142. THERAPEUTIC BCG VACCINE MARKET LICENSE & PRICING
目次
Product Code: MRR-030298DFF713

The Global Therapeutic BCG Vaccine Market is forecasted to grow significantly, with a projected USD 57.76 million in 2023 at a CAGR of 4.48% and expected to reach a staggering USD 78.63 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Therapeutic BCG Vaccine Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Therapeutic BCG Vaccine Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Immune BCG and Therapy BCG. The Immune BCG is projected to witness significant market share during forecast period.

Based on Demographics, market is studied across Adults and Pediatrics. The Adults is projected to witness significant market share during forecast period.

Based on End User, market is studied across Clinics and Hospitals. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Therapeutic BCG Vaccine Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Therapeutic BCG Vaccine Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Therapeutic BCG Vaccine Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Therapeutic BCG Vaccine Market?

4. What is the competitive strategic window for opportunities in the Global Therapeutic BCG Vaccine Market?

5. What are the technology trends and regulatory frameworks in the Global Therapeutic BCG Vaccine Market?

6. What is the market share of the leading vendors in the Global Therapeutic BCG Vaccine Market?

7. What modes and strategic moves are considered suitable for entering the Global Therapeutic BCG Vaccine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Therapeutic BCG Vaccine Market, by Type, 2022 vs 2030
  • 4.3. Therapeutic BCG Vaccine Market, by Demographics, 2022 vs 2030
  • 4.4. Therapeutic BCG Vaccine Market, by End User, 2022 vs 2030
  • 4.5. Therapeutic BCG Vaccine Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising infant population and growing advancement in the pediatric care
      • 5.1.1.2. High investment in research & development of therapeutic BCG vaccine
      • 5.1.1.3. Increasing awareness through vaccination campaign
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of therapeutic BCG vaccine
    • 5.1.3. Opportunities
      • 5.1.3.1. Untapped market in developing and underdeveloped countries
      • 5.1.3.2. Growing initiatives by United Nations (UN) for TB preventions
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with BCG vaccine
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Therapeutic BCG Vaccine Market, by Type

  • 6.1. Introduction
  • 6.2. Immune BCG
  • 6.3. Therapy BCG

7. Therapeutic BCG Vaccine Market, by Demographics

  • 7.1. Introduction
  • 7.2. Adults
  • 7.3. Pediatrics

8. Therapeutic BCG Vaccine Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Therapeutic BCG Vaccine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Therapeutic BCG Vaccine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Therapeutic BCG Vaccine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing